Mitochondrial Dysfunction as a Biomarker of Illness State in Bipolar Disorder: A Critical Review
Authors:
- Anna Giménez-PalomoAGAnna Giménez-Palomo
- Helena AndreuHAHelena Andreu
- Oscar de JuanOJOscar de Juan
- Luis OlivierLOLuis Olivier
- Iñaki OchandianoIOIñaki Ochandiano
- Lidia IlzarbeLILidia Ilzarbe
- Marc ValentíMVMarc Valentí
- Aldo StoppaASAldo Stoppa
- Cristian-Daniel LlachCLCristian-Daniel Llach
- Giulio PacenzaGPGiulio Pacenza
- Ana Cristina AndreazzaAAAna Cristina Andreazza
- Michael BerkMBMichael Berk
Open Access
- 28 November 2024
- journal article
- review article
- Published by MDPI AG in Brain Sciences
- Vol. 14 (12) , 1199
Abstract
Mitochondria are organelles involved in different cellular functions, especially energy production. A relationship between mitochondrial dysfunction and mood disorders, especially bipolar disorder (BD), has been reported in the scientific literature, which suggests altered energy production and higher levels of oxidative stress compared to healthy controls. Specifically, in BD, the hypothesis of a biphasic pattern of energy availability has been postulated according to mood states. Current evidence highlights the presence of mitochondrial dysfunction in BD and variations between the manic, depressive, and euthymic phases. These findings need to be confirmed in future studies to identify biomarkers that may lead to individualized management of patients with BD and also to identify profiles with a higher risk of presenting an unfavorable course of illness, which would enable the design of preventive and therapeutic strategies in determined subpopulations of patients with BD. The limitations of this review include the non-systematic methodology, variety of mitochondrial-related functions associated with BD, heterogeneous study designs, preliminary evidence for specific findings, and limited recommendations regarding the use of mitochondrial modulators in BD.Keywords
Funding Information
- NHMRC Leadership 3 Investigator grant (GNT2017131, PI18/00805, PI21/00787, PI21/00169, 2017 SGR 1365, SLT006/17/00357, 754907, EU.3.1.1, 945151, PI21/00169)
- Spanish Ministry of Science and Innovation (GNT2017131, PI18/00805, PI21/00787, PI21/00169, 2017 SGR 1365, SLT006/17/00357, 754907, EU.3.1.1, 945151, PI21/00169)
- ISCIII-Subdirección General de Evaluación (GNT2017131, PI18/00805, PI21/00787, PI21/00169, 2017 SGR 1365, SLT006/17/00357, 754907, EU.3.1.1, 945151, PI21/00169)
- Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement (GNT2017131, PI18/00805, PI21/00787, PI21/00169, 2017 SGR 1365, SLT006/17/00357, 754907, EU.3.1.1, 945151, PI21/00169)
- CERCA Programme (GNT2017131, PI18/00805, PI21/00787, PI21/00169, 2017 SGR 1365, SLT006/17/00357, 754907, EU.3.1.1, 945151, PI21/00169)
- European Union Horizon 2020 Research and Innovation Program (GNT2017131, PI18/00805, PI21/00787, PI21/00169, 2017 SGR 1365, SLT006/17/00357, 754907, EU.3.1.1, 945151, PI21/00169)
- Spanish Ministry of Science and Innovation (GNT2017131, PI18/00805, PI21/00787, PI21/00169, 2017 SGR 1365, SLT006/17/00357, 754907, EU.3.1.1, 945151, PI21/00169)
This publication has 145 references indexed in Scilit:
- N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trialsPsychopharmacology, 2020
- Antidepressant Action on Mitochondrial Dysfunction in Psychiatric DisordersDrug Development Research, 2016
- A genetic variant in CAMKK2 gene is possibly associated with increased risk of bipolar disorderJournal of Neural Transmission, 2015
- Mitochondria in metabolic disease: Getting clues from proteomic studiesProteomics, 2013
- The role of mitochondrial dysfunction in psychiatric diseaseDevelopmental Disabilities Research Reviews, 2010
- Mitochondrial Complex I Activity and Oxidative Damage to Mitochondrial Proteins in the Prefrontal Cortex of Patients With Bipolar DisorderArchives of General Psychiatry, 2010
- Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophreniaEuropean Child & Adolescent Psychiatry, 2009
- The Heritability of Bipolar Affective Disorder and the Genetic Relationship to Unipolar DepressionArchives of General Psychiatry, 2003
- How mitochondrial damage affects cell functionJournal of Biomedical Science, 2002
- Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorderCell Biochemistry and Function, 2002